← FDA Drug Approvals (Drugs@FDA)

BRAVELLE

BLA · Biologics License Application · Sponsor: FERRING · Approved 2002-05-06

Drug application

FDA Application #

BLA021289

Application type

Biologics License Application

Brand name

BRAVELLE

Generic name

Urofollitropin

Active ingredients

UROFOLLITROPIN

Dosage form

INJECTABLE

Route

INTRAMUSCULAR, SUBCUTANEOUS

Marketing status

Discontinued

Sponsor

FERRING

First approval

2002-05-06

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown